REFERENCES
- Phillips SM, Padgett LS, Leisenring WM, et al. Survivors of childhood
cancer in the United States: prevalence and burden of morbidity.Cancer Epidemiol Biomarkers Prev . 2016;24(4):653-663.
- Cheung AT, Li WHC, Ho LLK, Chan GCF, Chung JOK. Health support to
pediatric cancer survivors and their families during the COVID-19
pandemic [published online ahead of print, 2020 Aug
9]. Pediatr Blood Cancer . 2020;e28441.
- Nekhlyudov L, Duijts S, Hudson SV, et al. Addressing the needs of
cancer survivors during the COVID-19 pandemic. J Cancer
Surviv. 2020;14(5):601-606.
- Fung M, Babik JM. COVID-19 in Immunocompromised Hosts: What We Know So
Far [published online ahead of print, 2020 Jun 27]. Clin
Infect Dis. 2020;ciaa863.
- Verbruggen LC, Wang Y, Armenian SH, et al. Guidance regarding COVID-19
for survivors of childhood, adolescent, and young adult cancer: A
statement from the International Late Effects of Childhood Cancer
Guideline Harmonization Group. Pediatr Blood Cancer .
2020;67(12):e28702.
- Perkins JL, Chen Y, Harris A, et al. Infections among long-term
survivors of childhood and adolescent cancer: a report from the
Childhood Cancer Survivor Study. Cancer .
2014;120(16):2514-2521.
- Bryan A, Pepper G, Wener MH, et al. Performance Characteristics of the
Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise,
Idaho. J Clin Microbiol . 2020;58(8).
- Deeks JJ, Dinnes J, Takwoingi Y, et al. Antibody tests for
identification of current and past infection with
SARS-CoV-2. Cochrane Database Syst Rev . 2020;6(6):CD013652.
- Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in
Children With Cancer in New York City. JAMA Oncol.2020:e202028.
- NYC Department of Health. Coronavirus disease 2019 (COVID-19) Data.
2020; https://www1.nyc.gov/site/doh/covid/covid-19-data.page. Accessed
September 18, 2020.
- de Rojas T, Pérez-Martínez A, Cela E, Baragaño M, Galán V, Mata C,
Peretó A, Madero L. COVID-19 infection in children and adolescents
with cancer in Madrid. Pediatr Blood Cancer. 2020
Jul;67(7):e28397.
- Fuereder T, Berghoff AS, Heller G, et al. SARS-CoV-2 seroprevalence in
oncology healthcare professionals and patients with cancer at a
tertiary care centre during the COVID-19 pandemic. ESMO Open .
2020;5(5):e000889.
- Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for
SARS-CoV-2. JAMA. 2020;323(22):2249–2251.